• 1912 Citations
  • 22 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Su Jong Yu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Chronic Hepatitis B Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Liver Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 1912 Citations
  • 22 h-Index
  • 155 Article
  • 3 Review article
  • 2 Letter
  • 1 Comment/debate
Open Access
Hepatocellular Carcinoma
Fibrosis
Mortality

Comparison of models for tumor recurrence after liver transplantation for the patients with hepatocellular carcinoma: A multicenter long-term follow-up study

Lee, J. H., Chang, Y., Cho, Y., Lee, Y. B., Cho, E. J., Yu, S. J., Sinn, D. H., Kim, B. H., Kim, S. H., Yi, N. J., Lee, K. W., Kim, J. M., Park, J. W., Kim, Y. J., Yoon, J. H., Joh, J. W. & Suh, K. S., Sep 2019, In : Cancers. 11, 9, 1295.

Research output: Contribution to journalArticle

Open Access
Liver Transplantation
Hepatocellular Carcinoma
Recurrence
Neoplasms
Living Donors
1 Citation (Scopus)

Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma

Yoo, C., Park, J. W., Kim, Y. J., Kim, D. Y., Yu, S. J., Lim, T. S., Lee, S. J., Ryoo, B. Y. & Lim, H. Y., 15 Jun 2019, In : Investigational New Drugs. 37, 3, p. 567-572 6 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Safety
Disease-Free Survival
regorafenib
sorafenib
6 Citations (Scopus)

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

Park, E. S., Lee, A. R., Kim, D. H., Lee, J. H., Yoo, J. J., Ahn, S. H., Sim, H., Park, S., Kang, H. S., Won, J., Ha, Y. N., Shin, G. C., Kwon, S. Y., Park, Y. K., Choi, B. S., Lee, Y. B., Jeong, N., An, Y., Ju, Y. S., Yu, S. J. & 6 others, Chae, H. B., Yu, K. S., Kim, Y. J., Yoon, J. H., Zoulim, F. & Kim, K. H., 1 Jun 2019, In : Journal of Hepatology. 70, 6, p. 1093-1102 10 p.

Research output: Contribution to journalArticle

Open Access
Tenofovir
Chronic Hepatitis B
Hepatitis B virus
Mutation
Inhibitory Concentration 50
Hepatocellular Carcinoma
Recurrence
Liver
Survival
Hepatectomy